Clinical Trial Update: Chemoradiation With or Without Nimotuzumab in Treating Esophageal Cancer Patients Who Suffer With Recurrence in Regional Lymph Nodes After Esophagectomy [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial at Fudan University is evaluating chemoradiation with or without nimotuzumab for esophageal squamous cell carcinoma patients with region…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Nimotuzumab (nimotuzumab)

Snippet

Sponsor: Fudan University | Conditions: Esophageal Squamous Cell Carcinoma | Phase 2, Phase 3 | Status: UNKNOWN